Taysha Gene Therapies, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 20.00 M | $27.80 M | 0.00% | 8.00% |
RTW INVESTMENTS, LP | 05/15/2025 | 18.79 M | $26.12 M | 116.63% | 7.51% |
MORGAN STANLEY | 05/15/2025 | 16.85 M | $23.42 M | -4.50% | 6.26% |
FMR LLC | 05/12/2025 | 15.63 M | $21.73 M | -4.48% | 5.80% |
BLACKROCK, INC. | 05/02/2025 | 13.59 M | $18.89 M | 0.43% | 5.05% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 10.87 M | $15.11 M | 0.00% | 4.35% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 10.70 M | $14.87 M | 2.39% | 3.97% |
VANGUARD GROUP INC | 05/09/2025 | 8.77 M | $12.19 M | -1.53% | 3.26% |
SIREN, L.L.C. | 05/23/2025 | 6.51 M | $9.06 M | -1.33% | 2.42% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 4.57 M | $6.35 M | 100.00% | 1.70% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 4.00 M | $5.57 M | 0.00% | 1.60% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 05/15/2025 | 3.70 M | $5.14 B | 0.00% | 1.37% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.66 M | $5.10 M | 2.59% | 1.36% |
STATE STREET CORP | 05/15/2025 | 3.23 M | $4.49 M | -50.06% | 1.20% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 3.00 M | $4.17 M | 0.00% | 1.11% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 1.77 M | $2.46 M | 1,069.19% | 0.71% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.64 M | $2.28 M | 0.27% | 0.66% |
PALO ALTO INVESTORS LP | 05/15/2025 | 1.42 M | $1.97 M | 74.97% | 0.57% |
NORTHERN TRUST CORP | 05/13/2025 | 1.43 M | $1.99 M | -1.86% | 0.53% |
05/15/2025 | 1.26 M | $1.75 M | 30.03% | 0.50% | |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.07 M | $1.48 M | 500.04% | 0.43% |
JPMORGAN CHASE & CO | 05/12/2025 | 1.00 M | $1.39 M | -62.06% | 0.37% |
WOODLINE PARTNERS LP | 05/15/2025 | 858.25 K | $1.19 M | -16.47% | 0.32% |
QUANTUM PRIVATE WEALTH, LLC | 05/13/2025 | 791.48 K | $1.10 M | -0.44% | 0.29% |
SUPERSTRING CAPITAL MANAGEMENT LP | 05/15/2025 | 755.60 K | $1.05 M | 100.00% | 0.28% |
SANDS CAPITAL VENTURES, LLC | 05/14/2025 | 724.87 K | $1.01 M | 0.00% | 0.27% |
BARCLAYS PLC | 05/15/2025 | 708.97 K | $985.00 K | 111.48% | 0.26% |
ALPHABET INC. | 05/02/2025 | 640.88 K | $890.83 K | 0.00% | 0.24% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 636.84 K | $885.21 K | -62.76% | 0.24% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 625.20 K | $869.03 K | 6.76% | 0.23% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 522.50 K | $726.28 K | 0.00% | 0.21% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 547.13 K | $760.51 K | 15.37% | 0.20% |
05/12/2025 | 546.41 K | $759.52 K | 100.00% | 0.20% | |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 453.42 K | $630.25 K | 0.70% | 0.17% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 359.01 K | $499.02 K | -62.88% | 0.13% |
KOVITZ INVESTMENT GROUP PARTNERS, LLC | 05/19/2025 | 292.78 K | $406.96 K | 100.00% | 0.11% |
JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 245.25 K | $340.90 K | 100.00% | 0.09% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 227.47 K | $316.19 K | 59.67% | 0.08% |
CITADEL ADVISORS LLC | 05/15/2025 | 216.61 K | $301.09 K | -70.93% | 0.08% |
RHUMBLINE ADVISERS | 05/29/2025 | 205.46 K | $285.58 K | 6.97% | 0.08% |
XTX TOPCO LTD | 05/08/2025 | 203.13 K | $282.35 K | 100.00% | 0.08% |
INVESCO LTD. | 05/12/2025 | 159.90 K | $222.26 K | 83.05% | 0.06% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 05/05/2025 | 142.81 K | $198.51 K | 3.89% | 0.05% |
HRT FINANCIAL LP | 05/15/2025 | 139.69 K | $194.00 K | 100.00% | 0.05% |
ENTRYPOINT CAPITAL, LLC | 05/14/2025 | 135.90 K | $188.90 K | 120.99% | 0.05% |
PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 134.90 K | $187.51 K | 0.00% | 0.05% |
DEUTSCHE BANK AG\ | 05/09/2025 | 134.42 K | $186.84 K | -11.03% | 0.05% |
CITIGROUP INC | 05/12/2025 | 133.19 K | $185.14 K | -47.41% | 0.05% |
05/09/2025 | 117.06 K | $162.72 K | 100.00% | 0.04% | |
CHICAGO PARTNERS INVESTMENT GROUP LLC | 05/09/2025 | 116.57 K | $221.47 K | 0.45% | 0.04% |
Taysha Gene Therapies, Inc. institutional Ownership - FAQ's
During the previous two years, 145 institutional investors and hedge funds held shares of Taysha Gene Therapies, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 20 M
RTW INVESTMENTS, LP: 18.79 M
MORGAN STANLEY: 16.85 M
FMR LLC: 15.63 M
BlackRock, Inc.: 13.59 M
RA CAPITAL MANAGEMENT, L.P.: 10.87 M
61.92% of Taysha Gene Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 180.24 M shares in the last 24 months. This purchase volume represents approximately $488.44 M in transactions.